Fig. 6: Summary of the association between immune parameters and therapeutic response to trial treatment. | Nature Communications

Fig. 6: Summary of the association between immune parameters and therapeutic response to trial treatment.

From: Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial

Fig. 6

Group differences for each immune parameter (A non-PR vs PR for response before RTCT; B non-CR vs CR for response after RTCT; C non-CR vs CR for response at EOT) were evaluated using the two-sided Mann–Whitney U test with no adjustment for multiple comparisons. Graphs depicting –log10(P-values) of the immune parameters between the two groups (A non-PR vs PR; B non-CR vs CR; C non-CR vs CR) are shown. Sample sizes are presented in each panel. Source data are provided as a Source Data file. BL baseline, CR complete response, EOT end of treatment, PR partial response, RTCT chemoradiation, Teff T effector cells, Treg regulatory T cells.

Back to article page